National Voluntary Blood Services

Blood Safety Indicators Report Form

Program

GLOBAL DATABASE ON BLOOD SAFETY (GDBS) 2010

GLOBAL DATABASE ON BLOOD SAFETY

The World Health Organization (WHO) programme on Blood Transfusion Safety would appreciate your kind cooperation in completing
this questionnaire which has been designed to obtain information for the WHO Global Database on Blood Safety.
The GDBS was established by WHO to address global concerns about the availability, safety, and equitable accessibility of blood for
transfusion. It covers the four major components of the integrated strategy for blood safety advocated by WHO:
§         The establishment of well-organized, nationally-coordinated blood transfusion services with quality systems in all areas
§         The collection of blood from voluntary non-remunerated blood donors from low-risk populations and the phasing out of
family/replacement and paid donation
§         The screening of all donated blood for transfusion-transmissible infections, including HIV, hepatitis B and C, syphilis and other
infectious agents; blood grouping and compatibility testing
§         A reduction in unnecessary transfusions through the effective clinical use of blood.

The objective of the GDBS is to collect and analyse data from all Member States of WHO in order to enable the Organization to:
§         Obtain the best available information on blood transfusion services in each Member State
§         Assess the global situation on blood safety, availability and access and monitor trends and progress
§         Identify priority countries for support and technical assistance
§         Plan research and develop appropriate strategies to address specific needs.

The GDBS was initiated in 1998. GDBS reports are available on the WHO website (http://www.who.int/bloodsafety/global database/) and
from WHO Headquarters and Regional Offices. Please contact WHO for further information or assistance on completing the GDBS

DATA COLLECTION FOR THE PERIOD JANUARY - DECEMBER 2009

The GDBS questionnaire should be completed by an authorized person in the respective BSF. Please provide details of the person who
completes the questionnaire so that Philippine Blood Center can contact, if necessary, for clarification and further information.

The questionnaire should be completed with data for the period January to December 2010. If calendar year information is not
available, please provide information for the nearest 12-month period (e.g. April 2009 to March 2010),and indicate the period covered
on the form.

DATA COLLECTION QUESTIONNAIRE

You are requested to complete the electronic version of the questionnaire, if possible.
Please enter your responses only in the yellow boxes that are shown on the screen. The questionnaire has been protected to prevent
responses from being entered outside these boxes. You will also find that some boxes are grey in colour. These boxes contain formulae
and are also protected; automatic calculations will be made in these boxes as the relevant data are entered.
Options of "Yes" and "No" are offered for responses to qualitative questions. To answer this type of question, click on the box for your
preferred answer; a black point will then appear in the centre of the box. If you wish to change your answer, simply click on another
box. If you feel that a "Yes" or "No" answer alone is insufficient to capture some aspects of the situation in your country, please provide
further information in the "Comment" box at the bottom of each worksheet. Information provided through the "Comment" boxes is an
essential part of the data collected through this questionnaire. If you inadvertently click on a "Yes" or "No" box and wish to revert to the
previous setting where neither "Yes" nor "No" are selected, click on the grey portion of the box beside the choices, press the "Del" (or
"Delete") key (see figure below).

Automatic error checking has been incorporated into the electronic questionnaire. This is designed to prevent the entry of data that are
invalid or obviously incorrect. When such an error occurs, a message will appear to indicate the error and the entry will be rejected.
Before continuing, you should review and change the data just entered.

RETURNING THE GDBS QUESTIONNAIRE

Philippine Blood Center

IBBIS Department
BRL Building, Department of Health, Tayuman
Tel no. 7317578
E-mail: pbcbsi@gmail.com, pbcbsi@yahoo.com

Global Database on Blood Safety (GDBS) 2008 Page 1 of 7

 National Voluntary Blood
Blood Safety Indicators Report Form 2012
Services Program
v.1.1

Section 1: Administrative Information

1.1 Date July 10, 2019
1.2 Region Region 4A
1.3 Blood Service Facility/ Hospital
H.M. Corachea General Hospital

1.4 Classification Blood Station

Information provided by:

1.5 Name Danielle Jane P. Perez, RMT
1.6 Position Chief Medical Technologist
1.7 Organization H.M. Corachea General Hospital
1.8 Address
324 Brgy. Santor, Tanauan City, Batangas

1.9 Tel. no. (043) 778 1293

1.10 Fax no.
1.11 E-mail corachea.lab@gmail.com
1.12 Period covered by report January 2018- July 2019

Section 2: Blood Donors and blood collection

2.1 Do you use standard operating procedures (SOPs) or local written instruction for: Yes No
2.1.1 Blood donor recruitment ●

2.1.2 Pre-donation counselling and donor selection

2.1.3 Blood collection and donor care
2.1.4 Post-donation counselling
2.2 Do you maintain records of the following
2.2.1 Blood donor recruitment
2.2.2 Pre-donation counselling and donor selection
2.2.3 Blood collection and donor care
2.2.4 Post-donation counselling
2.3 How many blood donors donated whole blood during the reporting period?
2.3.1 Total number of donors who donated blood 0
2.3.2 Total number of voluntary non-remunerated donors who donated blood 0
2.4 How many deferrals were there from whole blood donation, by types of deferral?
2.4.1 Permanent deferral 0
2.4.2 Temporary deferral 0
2.4.3 Total number of deferrals 0
2.5 How many deferrals were there from whole blood donation, by reasons for deferral?
2.5.1 Low haemoglobin (in the old monitoring forms this is Hemoglobin) 0
2.5.2 Other medical conditions (in the old monitoring forms this is PE&Hx) 0
2.5.3 High-risk behaviour (in the old monitoring forms this is under TTDs) 0
2.5.4 Travel and other reasons (in the old monitoring forms this is under Other Reasons) 0
2.5.5 Total number of deferrals 0
 2.6 How many whole blood donations were collected, by types of donation?
2.6.1 Voluntary non-remunerated donations 0
2.6.2 Family/replacement donations 0
2.6.3 Paid donations 0
2.6.4 Total number of donations 0
2.7 How many whole blood donations were collected from:
2.7.1 Male donors
2.7.2 Female donors
2.7.3 Total number of donations 0
2.8 How many whole blood donations were collected from:
2.8.1 Donors under 18 years 0
2.8.2 Donors aged 18 to 24 years 0
2.8.3 Donors aged 25 to 44 years 0
2.8.4 Donors aged 45 to 64 years 0
2.8.5 Donors aged 65 years or older 0
2.8.6 Total number of donations 0
2.9 How many whole blood donations were collected from first-time voluntary non-remunerated
0
donors?
2.10 Donation: donor ratio for voluntary non-remunerated whole blood donors #DIV/0!
2.11 Are any blood donations collected through apheresis procedures?
If yes, how many apheresis donations were collected by types of donation?
2.11.1 Voluntary non-remunerated apheresis donations
2.11.2 Family/ replacement apheresis donations
2.11.3 Paid apheresis donations
2.11.4 Others (please specify):
2.11.5 Total number of apheresis donations 0
2.11.6 Total number of donors who donated through apheresis procedures during
reporting period
2.12 Do you have a system for post-donation counselling of blood donors who test positive
for transfusion-transmissible infections?
Section 3: Screening for transfusion-transmissible infections
3.1 Do you perform laboratory screening of blood donations for transfusion transmissible
infections?
3.1.1 Do you use EIA for screening blood donations for TTIs?
3.2 Do you use standard operating procedures or local written instructions for laboratory
screening of blood donations for transfusion transmissible infections?
3.3 Do you participate in an external quality assessment scheme/external evaluation or
performance for transfusion-transmissible infections?
3.4 How many donations (whole blood and apheresis) were screened for the following transfusion-transmissible
infections?
3.4.1 HIV 0 #DIV/0!
3.4.2 Hepatitis B 0 #DIV/0!
3.4.3 Hepatitis C 0 #DIV/0!
3.4.4 Syphilis 0 #DIV/0!
3.4.5 Malaria 0 #DIV/0!
3.5 How many donations (whole blood and apheresis) were: (a) reactive in the screening test; and (b) positive in
the confirmatory test?
Screening test Confirmatory test
TTI Markers
reactive positive
3.5.1 HIV 0 #DIV/0! 0 #DIV/0!
3.5.2 Hepatitis B 0 #DIV/0! 0 #DIV/0!
3.5.3 Hepatitis C 0 #DIV/0! 0 #DIV/0!
3.5.4 Syphilis 0 #DIV/0! 0 #DIV/0!
3.5.5 Malaria 0 #DIV/0! 0 #DIV/0!
3.6 What was the prevalence of the following TTI markers in donated blood during the reporting period?
3.6.1 HIV #DIV/0!
3.6.2 Hepatitis B #DIV/0!
3.6.3 Hepatitis C #DIV/0!
3.6.4 Syphilis #DIV/0!
3.6.5 Malaria #DIV/0!
3.7 Details in which screening for TTIs is performed: number of donations tested, use of standard operating
procedures (SOPs) and participation in external quality assessment/external evaluation of performance
Total Number of donations screened for each TTI SOPs used Participate in EQA
donations HIV HBV HCV Syphilis Malaria Yes No Yes No
0 0 0 0 0 0
3.8 Were any blood units issued without screening due to:
3.8.1 Non-availability of test kits/reagents
3.8.2 Emergency situations
3.8.3 Staff shortages
3.8.4 Equipment failure/breakdown/power loss
3.8.5 Other reasons (please specify)
Section 4: Blood group serology testing of blood donations
4.1 Do you perform blood group serology testing of blood donations?
4.1.1 Do you use tube method for blood group serology testing?
4.2 Do you use standard operating procedures or local written instructions for blood group
serology testing of blood donations?
4.3 Do you maintain records of blood group serology testing?
4.4 Do you participate in an external quality assessment scheme/external evaluation of
performance for blood serology?

Section 5: Blood component preparation, storage and transportation

5.1 Do you prepare blood components?
5.2 How many whole blood donations were separated into components? #DIV/0!
5.3 How many units of blood components were prepared from whole blood donations?
Component
5.3.1 Red cell preparations 0
5.3.2 Platelet concentrates 0
5.3.3 Plasma 0
5.3.4 Fresh Frozen Plasma 0
5.3.5 Cryoprecipitate 0
5.4 How many units of blood components were prepared through apheresis procedures?
5.4.1 Apheresis red cells 0
5.4.2 Apheresis platelets 0
5.4.3 Apheresis plasma 0
5.4.5 Total blood components 0
5.5 Do you use standard operating procedures or local written instructions for the
preparation of blood components?
5.6 Do you maintain records of blood component preparation?
5.7 Do you store whole blood and whole blood components in temperature-monitored
equipment?
5.8 Do you transport whole blood and whole blood components in temperature-monitored
equipment?
5.9 Do you store test kits and reagents in temperature-monitored equipment?
5.10 How many units of whole blood were discarded due to faulty collection? 0
5.11 How many units of whole blood and blood components were discarded due to other reasons?
Component Reason for discard
Processing Storage Transport Date
TTI Problem Total
Problem problem expiry
5.11.1 Whole blood 0
5.11.2 Red cells 0
5.11.3 Platelets 0
5.11.4 Plasma 0
5.11.5 Fresh frozen plasma 0
5.11.6 Cryoprecipitate 0
5.11.7 Total component discarded 0 0 0 0 0 0
Section 6: Hospital transfusion process and clinical use of blood & blood components
6.1 Do you perform blood transfusion?
6.2 Do you perform compatibility testing?
6.2.1 Do you use standard operating procedures or local written instructions for
compatibility testing?
6.2.2 Do you maintain records of compatibility testing?
6.2.3 Do you participate in an external quality assessment scheme/external evaluation
of performance for compatibility testing?
6.2.4 Do you store whole blood and whole blood components in temperature-monitored
equipment?
6.3 Do you participate in:
6.3.1 Hospital transfusion committee
6.3.2 System for monitoring clinical transfusion practice
6.3.3 System for reporting adverse transfusion incidents
6.4 How many patients were transfused?
6.5 How many patients were transfused by age and gender? Male Female
6.5.1 Patients under 5 years
6.5.2 Patients aged 5 to 14 years
6.5.3 Patients aged 15 to 44 years
6.5.4 Patients aged 45 to 59 years
6.5.5 Patients aged 60 years older
6.5.6 Total number of patients transfused by gender 0 0
6.6 How many units of each of the following blood components were transfused?
6.6.1 Whole blood
6.6.2 Red cells
6.6.3 Plasma and fresh frozen plasma
6.6.4 Platelets, whole blood-derive
6.6.5 Platelets, apheresis
6.6.6 Cryoprecipitate
6.7 Do you use standard operating procedures or local written instructions for the
transfusion of blood to patients?
6.8 Do you maintain records of blood transfusion to patients?
6.9 How many serious adverse transfusion incidents or reactions were reported?
Comment (optional)